(Q37331701)
Statements
Hypothesis: combined inhibition of complement and CD14 as treatment regimen to attenuate the inflammatory response (English)
Terje Espevik
2 references
Tom Eirik Mollnes
2 references
Dorte Christiansen
Ole-Lars Brekke